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Abstract. The purpose of this research is to analysis the potential Quercetin 3,4'-dimethyl ether
7-alpha-LArabinofuranosyl-(1-6)-glucoside as an inhibitor Plasmodium falciparum Enoyl Acyl
Carrier Protein Reductase (PfENR) compound for antimalaria. The method used to analysis
the potential Quercetin 3,4'-dimethyl ether 7-alpha-LArabinofuranosyl-(1-6)-glucoside as an
antimalaria was insilico approach by molecular docking using Autodock Vina. Based on the
free energy parameter analized ΔG, the value of free energy ΔG is -11.6 kcal /mol with 5
repetisions. The free energy ΔG value from the analysis results was relatively low, this means
that Quercetin 3,4'-dimethyl ether 7-alpha-LArabinofuranosyl-(1-6)-glucoside is stable to be
used as an inhibitor of Plasmodium falciparum Enoyl Acyl Carrier Protein Reductase (PfENR).
Because the lower the free energy of a molecule the more stable the molecule. Based on
hydrogen bond parameters, there were hydrogen bonds in Quercetin 3,4'-dimethyl ether 7-
alpha-LArabinofuranosyl-(1-6)-glucoside and PfENR receptors. This shows that Quercetin
3,4'-dimethyl ether 7-alpha-LArabinofuranosyl-(1-6)-glucoside binding PfENR receptors to
strong and stable. Based on the parameters of the analysis of Ligand and Receptor Interactions
also showed that Quercetin 3,4'-dimethyl ether 7-alpha-LArabinofuranosyl-(1-6)-glucoside
compounds were stable used as Plasmodium falciparum Enoyl Acyl Carrier Protein Reductase
(PfENR) inhibitors for antimalaria.
1. Introduction
Malaria is a very dangerous disease. 1.2% of people who die due to contracting malaria [1]. Malaria
usually threatens the lives of people living in tropical and subtropical regions. Malaria is an infectious
disease caused by the genus plasmodium parasite and transmitted by mosquitoes [2]. This disease
causes around one to two million deaths every year, or around one hundred fifty to three hundred
deaths every hour [3]. Malaria is characterized by symptoms of fever, fatigue, vomiting and
headaches. For severe cases, malaria can cause seizures, coma and even death [4].
Clinically malaria is divided into three types, namely tropical malaria caused by plasmodium
falciparum, tersiana malaria caused by plasmodium vivax and plasmodium ovale (rare, found outside
Africa), and quartane malaria caused by plasmodium malariae [5]. Malaria is transmitted through the
bite of a female Anopheles mosquito.
Plasmodium falciparum is the most deadly type of malaria for humans and has the highest priority
in finding effective drugs [6]. Clinical symptoms of P. falciparum malaria are generally more severe
and more acute than other types, characterized by fluctuating heat, anemia, splenomegaly, and
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frequent complications7. This malaria attacks all types of red blood cells, which causes cells to become
very fragile. The number of red blood cells damaged by parasitic infections disrupts transportation to
vital organs and can cause death quickly[7-8].
Plasmodium falciparum Enoyl Acyl Carrier Protein Reductase (PfENR) is an enzyme that plays an
important role in the plasmodium life cycle. This enzyme has an important role in the synthesis
process of fatty acids in the body Plasmodium falciparum [9]. This enzyme plays a role in type II fatty
acid biosynthesis that takes place in Plasmodium falciparum, with a specific target of Plasmodium
falciparum Enoyl Acyl Carrier Protein Reductase (PfENR). Inhibition of the enzyme Plasmodium
falciparum Enoyl Acyl Carrier Protein Reductase (PfENR) is the beginning of the development of
antimalarial drugs.
Some natural compounds have the potential to become new lead compounds that can inhibit the
enzyme Plasmodium falciparum Enoyl Acyl Carrier Protein Reductase (PfENR). This can be observed
if the enzyme compounds are tethered to some plant chemical compounds which are also efficacious
as an antimalarial. Quercetin 3,4'-dimethyl ether 7-alpha-L-Arabinofuranosyl- (1-6) -glucoside
compound is a compound derived from the Punicaceae family with plant species of origin namely,
Punica granatum, Malum granatum or commonly known as pomegranate. Research on extracts from
Punica granatum on antiplasmodial activity that has been carried out suggests that the tannin fraction
is useful to be an inhibitor of Plasmodium growth [10].
In this research, molecular docking analysis will be carried out to see the binding ability between
the enzyme Plasmodium falciparum Enoyl Acyl Carrier Protein Reductase (PfENR) against Quercetin
3,4'-dimethyl ether 7-alpha-L-Arabinofuranosyl (1-6) -glucoside enzyme inhibitor using the parameter
of the bond free energy value (ΔG) produced. Besides that, hydrogen bonding parameters and
interactions between receptors and ligands are also observed to see the stability of the bonds formed.
2. Method
This research uses computer hardware in the form of RAM (Random Access Memory) of at least eight
gigabytes. The software used is for the docking simulation process using Autodock vina 1.1.1 while
for the preparation and analysis of simulation results performed using the VMD (Visual Molecular
Dynamics Program) version 1.9.1, Autodock tools, and Pymol.
The material used in this research is experimental data of X-Ray Diffraction results in the form of
three-dimensional structural data of the enzyme Plasmodium falciparum Enoyl Acyl Carrier Protein
Reductase (PfENR). Plasmodium falciparum Enoyl Acyl Carrier Protein Reductase (PfENR) is used
as a receptor. Whereas the Ligand inhibitors used in this research are three-dimensional structures of
medicinal plants in Indonesia contained in the Indonesian Medicinal Plants Database namely
Quercetin compound 3,4'-dimethyl ether 7-alpha-L-Arabinofuranosyl- (1-6) – glucoside11.
2.1. Receptor Identification
The protein used as a receptor was the enzyme Plasmodium falciparum Enoyl Acyl Carrier Protein
Reductase (PfENR). The three-dimensional structure of PfENR downloaded from the Protein Data
Bank with the site http://www.rscb.org/pdb [11-12] with the identity of 1NHG in the form of a
tetramer. The identification process was done using Discovery Studio Visualizer 4.0 software.
2.2. Ligand Identification
Ligands that are used as inhibitors in this research are three-dimensional structures of medicinal plants
in Indonesia that found in the Indonesian Medicinal Plants Database. The ligand compound used as an
inhibitor is Quercetin 3,4'-dimethyl ether 7-alpha-L-Arabinofuranosyl- (1-6) -glucoside compound.
The crystal structure of the inhibitor (Ligan) was downloaded from the PubChem Database with the
site https://pubchem.ncbi.nlm.nih.gov.
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2.3. Geometry Optimization of 3D Receptor Structures
Geometry optimization process is carried out with Pymol software. The initial step is to separate the
receptor from the ligand and the solvent and then save it in the .pdb format. Furthermore, the receptor
and ligand files are converted back into a file with the extension .pdbqt using Autodock tools (ADT)
software. Furthermore, the size of the Grid Box is prepared. Grid Box is a ligand boundary measure
for docking receptors. The size is: center_x = 32.336, center_y = 45.963, center_z = 22.641, size_x =
82, size_y = 118 and size_z = 94
2.4. Geometry Optimization of 3D Ligand Structures
The optimization process is carried out by changing the ligand compound data format from the .sdf
format file to the .pdb file type. using pymol software. Furthermore, the receptor and ligand files are
converted back into a file with the extension .pdbqt using Autodock tools (ADT) software.
2.5. Molecular Docking Process
The molecular docking process is carried out with AutoDock Vina (Scripps Research Institute, USA)
and it is assumed that all rotatable bonds (cyclic bonds) of the ligands can rotate (flexible) and the
receptors are fixed (rigid) [13]. To run the docking needed, Vina's autodock software, receptor files,
ligands and config files. Config file is a file that contains the specified grid box size. After docking is
complete, a number of docking modes will be shown along with the value of Affinity (kcal/mol).
Repeated 5 times to see the best results and the consistency of the values obtained. Then the docking
analysis is performed.
2.6. Molecular Docking Analysis
Docking analysis using pymol and VMD software to see the parameters of free energy gibbs,
hydrogen bonds, and the interaction of ligand with receptor.
3. Result and Discussion
3.1. Receptor Identification
The three-dimensional structure of the enzyme Plasmodium falciparum Enoyl Acyl Carrier Protein
Reductase (PfENR) is downloaded from a protein data bank. The three-dimensional structure of the
enzyme Plasmodium falciparum Enoyl Acyl Carrier Protein Reductase (PfENR) is expressed from
bacteria. The enzyme Plasmodium falciparum Enoyl Acyl Carrier Protein Reductase (PfENR) was
obtained from the results of crystallization using x-ray diffraction. This enzyme has a 1NHG PDB
code and has a residual length of 229 residues. Visualization results show that there are 4 chains
namely A, B, C and D and there are two natural ligands TCL and NAD.
3.2. Ligand Identification
The ligand used is Quercetin 3,4'-dimethyl ether 7-alpha-L-Arabinofuranosyl- (1-6) -glucoside
compound.
Table 1. Quercetin 3,4'-dimethyl ether 7-alpha-L-
Arabinofuranosyl- (1-6) -glucoside compounds.
Pubcem CID 44259697
Molecular
Formula
C28H32O16
Molecular
Weight
624.5 g/mol
Hydrogen
Bond Donor
8
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Count
Hydrogen Bond
Acceptor Count
16
Structure
3.3. Bonding Energy (Gibbs free energy)
Gibbs free energy (ΔG binding) is a parameter for determining the stability of a conformation formed
between a ligand and a receptor. The lower the free energy of a reacting molecule, the more stable the
molecule formed and the reaction that occurs spontaneously. This is in accordance with the law of
thermodynamic balance. So, the more negative free energy of a molecule that reacts, the reaction goes
spontaneously and the molecule becomes more stable or will quickly form stable conformations14. The
molecular docking energy for Quercetin 3,4'-dimethyl ether 7-alpha-L-Arabinofuranosyl- (1-6) -
glucoside compound produces a final value of -11.6 kcal / mol consisting of 9 ligand modes. This
means that the Quercetin 3,4'-dimethyl ether 7-alpha-L-Arabinofuranosyl- (1-6) -glucoside compound
is stable for use as an inhibitor of the enzyme Plasmodium falciparum Enoyl Acyl Carrier Protein
Reductase (PfENR) because the lower free energy of a molecule, the more stable the molecule is
because the reaction goes spontaneously.
Table 2. Gibbs free energy results from molecular docking ligands.
Mode Affinity (kcal/mol)
dist from best
mode
rmsd
l.b. rmsd u.b
1 -11.6 0.000 7.948
2 -11.4 4.651 3.187
3 -11.3 2.519 2.397
4 -11.1 1.701 12.405
5 -10.9 9.189 11.231
6 -10.8 8.608 9.618
7 -10.7 6.905 7.530
8 -10.7 5.036 6.845
9 -10.7 3.794 7.948
If analyzed from the value of the free energy of gibbs produced, the Quercetin 3,4'-dimethyl ether
7-alpha-L-Arabinofuranosyl- (1-6) -glucoside compound is possible to be used as an anti-malarial
because the free energy is negative. Besides Quercetin 3,4'-dimethyl ether 7-alpha-L-
Arabinofuranosyl- (1-6) -glucoside ligand compound is also a compound that has antioxidant and
antiplasmodial activity.
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(a) (b)
Figure 1. Pose Ligand and receptor (a). Molecular Surface (b). The ribbon.
3.4. Hydrogen Bonding
Hydrogen bonding is an indicator of the stability of a molecule, although the effect is very small.
Because the energy produced is relatively small. But if the number of hydrogen bonds is large, then
the energy generated from the hydrogen bond parameter becomes large, so that it will be very
influential to stabilize a molecule.
Figure 2. Hydrogen bonding between H
atoms and Quercetin 3,4'-dimethyl ether
7-alpha-L-Arabinofuranosyl (1-6)
–glucoside ligand.
Figure 3. Interaction of receptors and
ligands.
The 4th International Conference on Applied Physics and Materials Application
Journal of Physics: Conference Series 1428 (2020) 012057
IOP Publishing
doi:10.1088/1742-6596/1428/1/012057
6
Based on the analyzed hydrogen bond parameters, the Plasmodium falciparum Enoyl Acyl Carrier
Protein Reductase (PfENR) receptor and ligand have 1 hydrogen bond, which is the bond between the
hydrogen atom and the UNK ligand from Quercetin 3,4'-dimethyl ether 7-alpha-L- Arabinofuranosyl-
(1-6) –glucoside compound (Figure 2). So it can be concluded that in the Quercetin 3,4'-dimethyl ether
7-alpha-L- Arabinofuranosyl- (1-6) –glucoside ligand the hydrogen bond does not have a significant
effect, because there is only 1 hydrogen bond formed.
3.5. Interaction of Ligands and Receptors
Hydrophobic interactions are interactions that avoid the liquid environment and tend to cluster in the
interior of the structure of globular proteins to minimize interactions with water that can damage the
structure of proteins and cause enzymes to lose their activity [15].
From hydrophobic interactions, it can be seen that Quercetin 3,4'-dimethyl ether 7-alpha-L-
Arabinofuranosyl- (1-6) -glucoside ligand stable to be used as an inhibitor for enzyme Plasmodium
falciparum Enoyl Acyl Carrier Protein Reductase (PfENR) because there is an hydrophobic interaction
which will increase stability. The hydrophobic residues from the reacting residues are LEU216,
TRP131 while the hydrophilic residues are GLY106, GLY104, ASN218, LYS240, ASP168, SER170.
Although the effect of the hydrophobic interaction is small because the residues that interact are only
two residues.
4. Conclusion
Based on the analysis of gibbs free energy parameters, it was stated that Quercetin 3,4'-dimethyl ether
7-alpha-L-Arabinofuranosyl- (1-6) -glucoside ligand stable when docked on the enzyme Plasmodium
falciparum Enoyl Acyl Carrier Protein Reductase (PfENR). This can be seen from the value of free
energy produced by gibbs that is - 11.6 kcal / mol. Negative values indicate that the system is stable.
The lower the free energy of a molecule, the more stable the molecule and the reaction runs
spontaneously. In addition, based on the parameters of hydrogen bonds and ligand-receptor
interactions also stated that the Quercetin 3,4'-dimethyl ether 7-alpha-L-Arabinofuranosyl- (1-6) -
glucoside was stable used as an inhibitor for the enzyme Plasmodium falciparum Enoyl Acyl Carrier
Protein Reductase (PfENR). There is 1 hydrogen bond formed between the ligand and the H atom. For
the parameters of the ligand-receptor interaction, there are hydrophobic residues and hydrophilic
residues reacting. The hydrophobic residues are LEU216, TRP131 while the hydrophilic residues are
GLY106, GLY104, ASN218, LYS240, ASP168, SER170. So that Quercetin 3,4'-dimethyl ether 7-
alpha-L-Arabinofuranosyl- (1-6) -glucoside ligand is potentially applied as a candidate for new
antimalarial drugs.
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